4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-19-062193
President sold 135,000 shares at an average $28.98 ($3,912,585)
- President acquired 135,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2019-12-27 | Option exercise | +35,000 | $0.45 | $15,750 | 35,000 | D |
| RUBINSTEIN JULIE President | 2019-12-27 | Option exercise | +45,000 | $0.45 | $20,250 | 80,000 | D |
| RUBINSTEIN JULIE President | 2019-12-27 | Sale | −80,000 | $29.28 | $2,342,400 | 0 | D |
| RUBINSTEIN JULIE President | 2019-12-30 | Option exercise | +55,000 | $0.45 | $24,750 | 55,000 | D |
| RUBINSTEIN JULIE President | 2019-12-30 | Sale | −51,500 | $28.51 | $1,468,265 | 3,500 | D |
| RUBINSTEIN JULIE President | 2019-12-30 | Sale | −3,500 | $29.12 | $101,920 | 0 | D |
| Derivatives | |||||||
| RUBINSTEIN JULIE President | 2019-12-27 | Option exercise · Stock Option (Right to Buy) | −35,000 | 0 | D | ||
| RUBINSTEIN JULIE President | 2019-12-27 | Option exercise · Stock Option (Right to Buy) | −45,000 | 55,000 | D | ||
| RUBINSTEIN JULIE President | 2019-12-30 | Option exercise · Stock Option (Right to Buy) | −55,000 | 0 | D | ||
| Open-market sales · 135,000 sh · avg $28.98 · $3,912,585 | |||||||
Loading xslF345X03/doc4.xml…